XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.2
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 1,554 $ 1,147 $ 2,740 $ 2,009
Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 4.12  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 3.96   $ 3.96  
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 88 109 $ 194 141
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Unrecognized Compensation Costs Related To Unvested Stock Options     390  
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 1,162 488 $ 1,806 972
Restricted Stock Units (RSUs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     747,425  
Granted, nonvested, number of shares (in shares)     450,232  
Vested, number of shares (in shares)     (448,883)  
Forfeited, number of shares (in shares)     (7,019)  
Number of nonvested shares, end of period (in shares) 741,755   741,755  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 4.77  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     7.36  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     6.18  
Vested, weighted average grant date fair value (in dollars per share)     4.24  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 6.64   $ 6.64  
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 304 $ 550 $ 740 $ 896
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     2,452,768  
Granted, nonvested, number of shares (in shares)     308,333  
Exercised, number of shares (in shares)     (536,094)  
Forfeited, number of shares (in shares)     (10,826)  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations     0  
Number of nonvested shares, end of period (in shares) 2,214,181   2,214,181  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 4.07  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     7.36  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised, Weighted Average Exercise Price     2.92  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     4.74  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired, Weighted Average Grant Date Fair     0  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 4.80   $ 4.80  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number 556,049   556,049  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price $ 2.92   $ 2.92  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms     2 years 2 months 8 days  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term     6 months 21 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 3,710   $ 3,710  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value $ 1,846   $ 1,846  
Stock Appreciation Rights (SARs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     1,360,625  
Granted, nonvested, number of shares (in shares)     308,333  
Vested, number of shares (in shares)     0  
Forfeited, number of shares (in shares)     (10,826)  
Number of nonvested shares, end of period (in shares) 1,658,132   1,658,132  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 2.81  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     3.45  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     3.25  
Vested, weighted average grant date fair value (in dollars per share)     0  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 2.92   $ 2.92